Clinical differences between younger and older adults with HIV/AIDS starting antiretroviral therapy in Uganda and Zimbabwe: a secondary analysis of the DART trial

Clinical differences between younger and older adults with HIV/AIDS starting antiretroviral therapy in Uganda and Zimbabwe: a secondary analysis of the DART trial

OBJECTIVE: Clinical and immunological data about HIV in older adults from low and middle income countries is scarce. We aimed to describe differences between younger and older adults with HIV starting antiretroviral therapy in two low-income African countries. METHODS: SETTING: HIV clinics in Ugand...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors:	Parikh, S, Obuku, E, Walker, SA, Semeere, A, Auerbach, B, Hakim, J, Mayanja-Kizza, H, Mugyenyi, P, Salata, R, Kityo, C
Format:	Journal article
Sprog:	English
Udgivet:	Public Library of Science 2013

Lignende værker

Clinical differences between younger and older adults with HIV/AIDS starting antiretroviral therapy in Uganda and Zimbabwe: a secondary analysis of the DART trial.
af: Sujal M Parikh, et al.
Udgivet: (2013-01-01)

The impact of first year adherence to antiretroviral therapy on long-term clinical and immunological outcomes in the DART trial in Uganda and Zimbabwe.
af: Kiwuwa-Muyingo, S, et al.
Udgivet: (2012)

Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe.
af: Walker, A, et al.
Udgivet: (2012)

HIV-associated anemia after 96 weeks on therapy: determinants across age ranges in Uganda and Zimbabwe.
af: Jaganath, D, et al.
Udgivet: (2014)

Cost Effectiveness Analysis of Clinically Driven versus Routine Laboratory Monitoring of Antiretroviral Therapy in Uganda and Zimbabwe
af: Lara, A, et al.
Udgivet: (2012)

Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and Zimbabwe.
af: Muyingo, S, et al.
Udgivet: (2008)

Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe.
af: Antonieta Medina Lara, et al.
Udgivet: (2012-01-01)

Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort.
af: Walker, A, et al.
Udgivet: (2010)

Impact of second-line antiretroviral regimens on lipid profiles in an African setting: the DART trial sub-study.
af: Gomo, Z, et al.
Udgivet: (2014)

Prevalence and factors associated with hypertension among people living with HIV/AIDS on antiretroviral therapy in Uganda
af: Gloria Lubega, et al.
Udgivet: (2021-02-01)

High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the DART trial
af: Kityo, C, et al.
Udgivet: (2014)

Provision of antiretroviral therapy in a rural setting – The Nile treatment centre experience, Uganda
af: Obuku Anthony, et al.
Udgivet: (2006-12-01)

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial.
af: Mugyenyi, P, et al.
Udgivet: (2010)

Evaluating the cost-effectiveness of combination antiretroviral therapy for the prevention of mother-to-child transmission of HIV in Uganda
af: Andreas Kuznik, et al.
Udgivet: (2012-08-01)

Antiretroviral Treatment-Associated Tuberculosis in a Prospective Cohort of HIV-Infected Patients Starting ART
af: William Worodria, et al.
Udgivet: (2011-01-01)

DART and laboratory monitoring of HIV treatment Reply
af: Walker, A, et al.
Udgivet: (2010)

Retention and predictors of attrition among patients who started antiretroviral therapy in Zimbabwe's national antiretroviral therapy programme between 2012 and 2015.
af: Richard Makurumidze, et al.
Udgivet: (2020-01-01)

High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the DART trial.
af: Cissy Kityo, et al.
Udgivet: (2014-01-01)

Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trial.
af: Ssali, F, et al.
Udgivet: (2006)

Cost-effectiveness of early initiation of first-line combination antiretroviral therapy in Uganda
af: Sempa Joseph, et al.
Udgivet: (2012-09-01)

The effect of AIDS defining conditions on immunological recovery among patients initiating antiretroviral therapy at Joint Clinical Research Centre, Uganda
af: Odere Mathew, et al.
Udgivet: (2009-07-01)

Agreement between physicians and non-physician clinicians in starting antiretroviral therapy in rural Uganda
af: Vasan Ashwin, et al.
Udgivet: (2009-08-01)

Long-term antiretroviral treatment adherence in HIV-infected adolescents and adults in Uganda: a qualitative study
af: Inzaule, S, et al.
Udgivet: (2016)

A randomized, controlled, trial of short cycle intermittent compared to continuous antiretroviral therapy for the treatment of HIV infection in Uganda.
af: Steven J Reynolds, et al.
Udgivet: (2010-04-01)

Hypertension and associated risk factors in individuals infected with HIV on antiretroviral therapy at an urban HIV clinic in Uganda
af: Aggrey S Semeere, MMed MAS, et al.
Udgivet: (2014-05-01)

Validation of World Health Organisation HIV/AIDS clinical staging in predicting initiation of antiretroviral therapy and clinical predictors of low CD4 cell count in Uganda.
af: Steven Baveewo, et al.
Udgivet: (2011-01-01)

Causes and timing of mortality and morbidity among late presenters starting antiretroviral therapy in the REALITY trial
af: Post, F, et al.
Udgivet: (2018)

Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy.
af: Reid, A, et al.
Udgivet: (2008)

Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative Study.
af: Seth C Inzaule, et al.
Udgivet: (2016-01-01)

The Clinical Presentation and Factors Associated with Disease Severity of Rheumatoid Arthritis in Uganda: A Cross-Sectional Study
af: Ochola B, et al.
Udgivet: (2022-05-01)

Immediate start of antiretroviral, why not?
af: Elaine Monteiro Matsuda, et al.

Patient-mix, programmatic characteristics, retention and predictors of attrition among patients starting antiretroviral therapy (ART) before and after the implementation of HIV "Treat All" in Zimbabwe.
af: Richard Makurumidze, et al.
Udgivet: (2020-01-01)

First‐line antiretroviral therapy durability in a 10‐year cohort of naïve adults started on treatment in Uganda
af: Barbara Castelnuovo, et al.
Udgivet: (2016-01-01)

Outcomes in a Cohort of Patients Started on Antiretroviral Treatment and Followed up for a Decade in an Urban Clinic in Uganda.
af: Barbara Castelnuovo, et al.
Udgivet: (2015-01-01)

Correction: Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative Study.
af: Seth C Inzaule, et al.
Udgivet: (2017-01-01)

Assessment of second-line antiretroviral regimens for HIV therapy in Africa
af: Paton, N, et al.
Udgivet: (2014)

AIDS-associated Kaposi sarcoma in Uganda: response to treatment with highly active antiretroviral therapy and chemotherapy
af: Johnston C, et al.
Udgivet: (2009-06-01)

A 10-year retrospective study of lung cancer in Uganda
af: Naghib Bogere, et al.
Udgivet: (2022-02-01)

Prevalence of overweight and obesity among adolescents living with HIV after dolutegravir - based antiretroviral therapy start in Kampala, Uganda
af: Irene Nakatudde, et al.
Udgivet: (2024-04-01)

Uptake of community antiretroviral group delivery models for persons living with HIV in Arua district, Uganda: A parallel convergent mixed methods study.
af: Wani Muzeyi, et al.
Udgivet: (2023-01-01)